Last reviewed · How we verify
IANB Articaine
At a glance
| Generic name | IANB Articaine |
|---|---|
| Also known as | Articadent (Dentsply Pharmaceutical) |
| Sponsor | University of Michigan |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Comparison of Anesthetic Efficacy OF 2% Lidocaine Inferior Alveolar Nerve (IANB) Block Versus Primary Buccal Infilteration With 4% Articaine in Symptomatic Irreversible Pulpitis(SIP) IN Mandibular First Molars (NA)
- Pain and Anxiety in Pediatric Dentistry: Computer-Controlled vs. Traditional Anesthesia (NA)
- Effect of Dental Anxiety on Mandibular Anesthesia Success (NA)
- Effectiveness of Digital Anesthesia Versus Conventional Techniques in Reducing Pain and Anxiety in Children (NA)
- Infiltration Anesthesia vs. Block Anesthesia (NA)
- Menstrual Cycle Effects on Postoperative Sensitivity and Rebound Pain in Composite Restorations (NA)
- Anesthetic Efficacy of Articaine and Lidocaine in Lower Molars With Irreversible Pulpits (PHASE4)
- Effect of Preoperative Oral Ibuprofen on Anesthetic Efficacy of Inferior Alveolar Nerve Block With Supplemental Buccal and Lingual Infiltrations Using Articaine in Mandibular Molar Teeth With Irreversible Pulpitis (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- IANB Articaine CI brief — competitive landscape report
- IANB Articaine updates RSS · CI watch RSS
- University of Michigan portfolio CI